FDUS vs JAZZ · P/E 8.7, $712.8M cap vs P/E 1988, rev $4.07B
Fidus Investment Corp (FDUS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Fidus Investment Corp (FDUS) is a asset management company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
FDUS does not have a complete income-statement cache yet.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FDUS currently screens at market cap $712.8M and trailing P/E 8.7. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FDUS and JAZZ stock pages for the full models.
Not investment advice.